C20orf202, short for "chromosome 20 open reading frame 202," is a protein encoded by a gene that resides on the 20th chromosome. This designation suggests that the protein is a product of a gene that was initially identified based on genomic sequencing projects, where it was recognized as an open reading frame-a sequence of DNA that is predicted to encode a protein-yet its biological function was not immediately clear.The functional characterization of C20orf202 is limited, reflecting the broader challenge in the post-genomic era of assigning roles to the numerous proteins that have been identified through these sequencing efforts. In the absence of detailed functional information, proteins like C20orf202 often become the subject of intense research to unravel their roles in cellular physiology and development.
Putative functions for C20orf202 might be hypothesized based on its amino acid sequence, domain structure, evolutionary conservation, expression pattern, and subcellular localization. For instance, if C20orf202 is conserved across species that share certain physiological traits, researchers might suspect that the protein plays a role in these conserved processes. Similarly, if C20orf202 contains domains that are known to participate in specific types of protein-protein interactions, it may be involved in corresponding signaling pathways or cellular structures.Altered expression or mutation of C20orf202 could potentially be associated with phenotypic consequences, contributing to disease pathology or affecting normal biological processes. Such associations can be identified through genetic studies linking variations in the C20orf202 gene to specific health conditions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor, potentially affecting cell growth and proliferation pathways that could be relevant to C20orf202. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, involved in key signaling pathways related to cell survival and proliferation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K), influencing various cellular processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 specifically inhibits MEK in the MAPK/ERK pathway, involved in cell differentiation and proliferation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK1/2 inhibitor, affecting the MAPK/ERK signaling pathway, potentially relevant to C20orf202. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, impacting stress-related cellular pathways and inflammatory responses. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which is involved in apoptosis, inflammation, and cellular differentiation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor, affecting protein degradation and multiple signaling pathways. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits the proteasome, leading to the accumulation of proteins and affecting cell cycle and apoptosis. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
Z-VAD-FMK is a pan-caspase inhibitor, potentially affecting apoptosis pathways related to C20orf202. | ||||||